| Business
Wire January 22, 2009
06:00 AM Eastern Time
UnitedHealth
Group Reports 2008 Financial Results
MINNEAPOLIS--(BUSINESS
WIRE)--UnitedHealth Group
(NYSE:UNH):
| Full
Year Results
|
|
Fourth
Quarter Results |
- Revenues Exceeded $81
Billion, Up 8%
- Adjusted Net Earnings Per
Share of $2.951
- Adjusted Operating Margin of
7.8%1
- Adjusted Cash Flows from
Operations of $4.8 Billion1
|
|
- Revenues of $20.5 Billion, Up
9%
- Adjusted Net Earnings Per
Share of $0.781
- Adjusted Operating Margin of
7.9%1
- Cash Flows from Operations of
$1.6 Billion
|
UnitedHealth Group (NYSE:UNH) today
reported fourth quarter and full year 2008 results, which
included strong cash flows from operations, a continued
strong balance sheet and financial position, and key
financial measures and medical cost trends well in line
with Company expectations. Continuing growth in the
Public and Senior Markets Group drove total net growth of
95,000 people served across all medical benefit product
categories in the fourth quarter of 2008.
Stephen J. Hemsley, president and chief
executive officer of UnitedHealth Group, said, During
2008 we effectively strengthened performance, improving
our position despite the challenging economic
environment. In 2009 we expect meaningful growth in our
government-sponsored businesses as well as a
year-over-year improvement in their product mix. There is
strong interest in our Medicare market offerings and
continued expansion from our state and public health
program relationships, including growth in public sector
specialty benefits. Notable improvements in our
commercial health benefit businesses are taking root,
including gains in fundamental operating performance and
local market momentum.
Full year net earnings were $2.40 per
share; adjusted for special items, the Company earned
$2.95 per share in 2008.
Fourth quarter net earnings of $0.60 per
share included an $0.18 per share charge to operating
costs for the previously announced resolution of class
action litigation for out of network medical services;
adjusted fourth quarter net earnings were $0.78 per
share. Both reported and adjusted fourth quarter earnings
per share included $0.03 per share in net realized
capital losses, primarily due to venture capital
investment write-downs, partially offset by $0.01 per
share pertaining to an insurance recovery on a previously
reported legal settlement. The net realized capital
losses, the costs of the legal matter from third quarter
2008 and the subsequent fourth quarter insurance recovery
have not been treated as special items in the Companys
financial statements.
Earnings Outlook
The Company is maintaining its previously
announced 2009 outlook for net earnings in the range of
$2.90 to $3.15 per share.
UnitedHealth Group
|
|
| Quarterly and
Annual Financial Performance |
| |
|
|
|
|
|
|
| |
|
Three Months
Ended |
|
Year Ended |
| |
|
December 31,
2008 |
|
September 30,
2008 |
|
December 31,
2007 |
|
December 31,
2008 |
|
December 31,
2007 |
| Revenues |
|
$20.45 billion
|
|
$20.16 billion
|
|
$18.71 billion
|
|
$81.19 billion
|
|
$75.43
billion |
| Earnings From
Operations |
|
$1.62 billion1
|
|
$1.56 billion1
|
|
$2.04 billion |
|
$6.35 billion1
|
|
$8.03 billion1
|
| Operating
Margin |
|
7.9%1
|
|
7.7%1
|
|
10.9% |
|
7.8%1
|
|
10.6%1
|
Management views year-over-year
comparisons of results to be generally more meaningful
than sequential comparisons, given the seasonality of
revenues, medical expenses, operating costs and earnings
from operations in important business lines such as
Medicare Part D drug programs, high deductible insurance
products and health informatics offerings.
UnitedHealth Group Highlights
- Full
year revenues of $81.2 billion increased $5.8
billion or 8 percent year-over-year, with fourth
quarter revenues of $20.5 billion increasing $1.7
billion or 9 percent year-over-year. UnitedHealth
Group served 73 million people at year end, an
increase of 1.9 million people year-over-year.
The UnitedHealthcare, Ovations, AmeriChoice,
OptumHealth, and Ingenix businesses each reported
revenue increases in 2008.
- Full
year adjusted earnings from operations were $6.35
billion and adjusted net earnings were $3.7
billion1.
Fourth quarter adjusted earnings from operations
were $1.6 billion and adjusted net earnings were
$941 million1.
The adjusted full year operating margin of 7.8
percent in 2008 decreased 280 basis points from
the prior year. The decreases in earnings and
margins were primarily driven by a reduction in
gross margin in risk-based health benefit
products, as well as a 100 basis point
year-over-year increase in the level of operating
costs as a percentage of revenue and a $373
million year-over-year reduction in investment
and other income, including $6 million in net
realized capital losses in 2008.
- On an
adjusted basis, full year net earnings were $2.95
per share and fourth quarter net earnings were
$0.78 per share. Full year 2008 net earnings were
$2.40 per share; fourth quarter earnings were
$0.60 per share.
- The
2008 consolidated medical care ratio of 82.0
percent increased 140 basis points
year-over-year, as premium rates advanced more
slowly than medical costs in 2008 for certain
risk-based products in the commercial, senior and
behavioral care markets. These factors also
caused the fourth quarter 2008 medical care ratio
to increase 90 basis points year-over-year to
80.8 percent.
- For
full year 2008 the Company realized $230 million
in net favorable development in its estimates of
medical costs incurred in prior years, compared
to $420 million in 2007. This includes $20
million of prior year favorable development
realized in the fourth quarter of 2008, compared
to $70 million in the fourth quarter of 2007.
- In
fourth quarter 2008 the Company also realized
$150 million in favorable development in its
estimates of medical costs incurred during the
first nine months of the year, compared to $10
million in the fourth quarter of 2007.
- Full
year adjusted operating costs of 14.8 percent1
of revenues increased 100 basis points in 2008
from 13.8 percent1
in 2007. The full year increase reflected changes
in business mix, as well as increases in the
Companys operating cost structure in excess
of business growth in the first half of 2008.
Adjusted operating costs were 15.4 percent1
and 14.4 percent of revenues in the fourth
quarters of 2008 and 2007, respectively,
reflecting higher seasonal cost levels. Since the
first quarter of 2008, UnitedHealth Group has
taken actions to reduce annual run rate operating
costs by about $470 million, a portion of which
has been reinvested into the business.
- UnitedHealth
Group realized a net capital loss of $6 million
from its $21.6 billion investment portfolio in
2008. Fourth quarter 2008 results included $14
million in net realized capital losses on fixed
income investments and a $50 million write-down
on the Companys approximately $200 million
venture capital investment program.
- The
2008 adjusted income tax rate of 35.9 percent1
decreased 40 basis points year-over-year, due to
an increased proportion of tax-free income. The
fourth quarter adjusted income tax rate was 35.7
percent1.
- Fourth
quarter 2008 days sales outstanding of 9 compares
to 9 days sales outstanding in the third quarter
of 2008 and 8 days outstanding at the end of
2007.
- Consolidated
medical costs days payable of 53 days in the
fourth quarter of 2008 compares to 54 days in the
third quarter of 2008 and 57 days at the end of
2007. The year-over-year decrease in medical days
payable was driven by an increased mix of
pharmacy benefit business, which has shorter
claims payment cycles, as well as the timing of
certain pharmacy benefit claims payments made at
year end 2008.
- Cash
flows from operations of $1.6 billion increased
$531 million from $1.1 billion in last years
fourth quarter, reflecting strong cash
collections in the quarter. Full year adjusted
cash flows from operations1
were 1.3 times 2008 adjusted net earnings1.
- UnitedHealth
Group reduced its debt to debt plus equity ratio
to 38.1 percent at December 31, 2008, down from
39.2 percent at September 30, 2008. Fourth
quarter net repayments of $485 million in
commercial paper obligations left only $101
million in commercial paper outstanding at the
end of the year. The Company also repurchased 8
million shares of its stock during the fourth
quarter of 2008.
- The
Company closed the year with $865 million in
unrestricted cash.
UnitedHealthcare
Ovations
AmeriChoice
Business Description Health Care
Services
Health Care Services provides
network-based health care benefits and services for a
full spectrum of customers. UnitedHealthcare serves
employers ranging from sole proprietorships to large,
multi-site and national employers, as well as students
and individuals. In the Public and Senior Markets Group,
Ovations delivers health and well-being services to
Americans over the age of 50, while AmeriChoice manages
health care services for state Medicaid and other
publicly funded programs and their beneficiaries.
|
|
| Quarterly and
Annual Financial Performance |
| |
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months
Ended |
|
Year Ended |
| |
|
December 31,
2008 |
|
September 30,
2008 |
|
December 31,
2007 |
|
December 31,
2008 |
|
December 31,
2007 |
| Revenues |
|
$19.08 billion
|
|
$18.82 billion
|
|
$17.57 billion
|
|
$75.86 billion
|
|
$71.20
billion |
Earnings From
Operations |
|
$1.27 billion |
|
$1.29 billion |
|
$1.60 billion |
|
$5.07 billion |
|
$6.60 billion
|
Operating
Margin |
|
6.6% |
|
6.8% |
|
9.1% |
|
6.7% |
|
9.3% |
Key Developments for Health Care Services
- Full
year Health Care Services revenues increased $4.7
billion or 7 percent to $75.9 billion, with
growth in revenues balanced across the
commercial, senior and public sector businesses.
Fourth quarter 2008 revenues increased $1.5
billion or 9 percent year-over-year to $19.1
billion. The revenue increases were driven by
premium increases, targeted acquisitions and an
increase in customers served in the Public and
Senior Markets Group, partially offset by a
decline in consumers served through commercial
risk-based products.
- Full
year Health Care Services earnings from
operations decreased $1.5 billion year-over-year
to $5.1 billion; fourth quarter Health Care
Services earnings from operations were $1.3
billion. Reductions in commercial product margins
and risk-based enrollment, and margin pressures
on certain senior market offerings negatively
impacted profitability year-over-year in the
fourth quarter and for full year 2008.
- Full
year UnitedHealthcare revenues of $41.8 billion
increased by $1.6 billion or 4 percent
year-over-year. Fourth quarter revenues of $10.5
billion for UnitedHealthcare increased $423
million or 4 percent year-over-year.
- At
year end UnitedHealthcare served 26 million
people, an increase of 0.8 million consumers
during 2008. UnitedHealthcare fourth quarter
membership decreased, as expected, with growth of
10,000 people using fee-based products offset by
a decline of 135,000 risk-based consumers in the
quarter.
- UnitedHealthcares
2008 medical care ratio of 83.5 percent increased
90 basis points from 82.6 percent in 2007, due
principally to premium yield increases advancing
more slowly than medical cost trends. The fourth
quarter 2008 medical care ratio was 83.9 percent,
slightly ahead of Company expectations.
- UnitedHealthcare
continued to advance its leadership position in
consumer-directed health benefit products in
2008, ending the year with a total of 2.7 million
people in consumer-directed offerings, an
increase of 420,000 people or 18 percent
year-over-year. More than 24,000 employer groups
now offer a UnitedHealthcare consumer-directed
health benefit plan.
- Full
year Ovations revenues of $28.1 billion increased
$1.6 billion or 6 percent year-over-year, with
revenue advances in its AARP Medicare Supplement,
SecureHorizons Medicare Advantage and Evercare
businesses, offset by a decrease in Part D
prescription drug plan revenues. Ovations
revenues were $6.8 billion in the fourth quarter,
up $570 million or 9 percent year-over-year.
- For
Medicare Advantage programs, Ovations reported
fourth quarter growth of 15,000 people and a full
year increase of 125,000 people or 9 percent.
2009 Medicare Advantage new sales results have
also been very solid to date.
- Strong
growth in Medicare Supplement products also
continued, with Ovations increasing the number of
seniors served in this product family by 30,000
in the fourth quarter, and 140,000 or 6 percent
on a year-over-year basis.
- As
expected, the medical care ratio for the Ovations
businesses in total increased year-over-year in
the fourth quarter and for full year 2008 due to
margin pressures affecting Special Needs Plans,
Medicare Part D prescription drug plans and
Medicare Advantage products, where risk-adjusted
revenue yields have been lower than originally
anticipated.
- AmeriChoice
full year revenues of $6.0 billion increased $1.5
billion or 34 percent in 2008, driven by
increased membership from organic growth and
geographic expansion via acquisition. Fourth
quarter revenues increased $515 million or 43
percent year-over-year to $1.7 billion.
- The
Company serves 2.5 million people in state-based
public market programs, an increase of 805,000
people in 2008. Medicaid membership grew
organically by 425,000 people or 25 percent
year-over-year, including growth of 175,000
people in the fourth quarter. Growth highlights
in 2008 include the states of Florida, Tennessee,
Arizona, and Connecticut, and the District of
Columbia, awarding or renewing significant
multi-year contracts with AmeriChoice for
services commencing in 2008 and 2009.
OptumHealth(SM)
Business Description OptumHealth
OptumHealth is one of the nations
leading health and wellness companies. Employers, payers
and public sector organizations use OptumHealth
behavioral benefit solutions, clinical care management,
financial services and specialty benefit products such as
dental and vision. OptumHealth helps consumers navigate
the health care system, finance their health care needs
and achieve their health and well-being goals.
|
|
| Quarterly and
Annual Financial Performance |
| |
|
|
|
|
| |
|
Three Months
Ended |
|
Year Ended |
| |
|
December 31,
2008 |
|
September 30,
2008 |
|
December 31,
2007 |
|
December 31,
2008 |
|
December 31,
2007 |
| Revenues |
|
$1.31 billion |
|
$1.29 billion |
|
$1.26 billion |
|
$5.23 billion
|
|
$4.92 billion
|
Earnings From
Operations |
|
$177 million |
|
$175 million |
|
$239 million |
|
$718 million |
|
$895 million |
Operating
Margin |
|
13.6% |
|
13.5% |
|
19.0% |
|
13.7% |
|
18.2% |
Key Developments for OptumHealth
- Full
year OptumHealth revenues increased $304 million
or 6 percent to $5.2 billion, including an
increase of $51 million or 4 percent
year-over-year in the fourth quarter. OptumHealth
provided services to approximately 60 million
consumers at year end, an increase of 1 million
people in 2008.
- Full
year 2008 earnings from operations decreased by
$177 million or 20 percent to $718 million.
Fourth quarter earnings from operations of $177
million decreased $62 million or 26 percent
year-over-year. These decreases were primarily
due to the mix effect of declining commercial
risk-based membership and margin pressure in the
behavioral health business, partially offset by
growth in lower margin public sector accounts.
OptumHealths operating margin was 13.6
percent in the fourth quarter and 13.7 percent
for full year 2008.
- OptumHealths
public sector service business continues to grow
strongly, with significant benefits sales in New
York, Tennessee and New Mexico each taking effect
in 2008 or expected to commence in 2009.
- OptumHealth
Financial Services, the nations largest
dedicated health banking organization, ended 2008
with $660 million in assets under management, an
increase of 43 percent year-over-year.
OptumHealth Financial Services electronically
transmitted $26 billion in medical payments to
physicians and other health care providers in
2008, a year-over-year increase of 38 percent.
- OptumHealth
closed 2008 as the market-leading operator of
independent web-based health care portal
services, with more than 1,000 private health
portals under management, including its recently
launched flagship, myoptumhealth.com.
Ingenix(R)
Business Description Ingenix
Ingenix is a leader in the field of health
care information, services and consulting, serving
pharmaceutical companies, health insurers and other
payers, physicians and other health care providers, large
employers and governments.
|
|
| Quarterly and
Annual Financial Performance |
| |
|
|
|
|
| |
|
Three Months
Ended |
|
Year Ended |
| |
|
December 31,
2008 |
|
September 30,
2008 |
|
December 31,
2007 |
|
December 31,
2008 |
|
December 31,
2007 |
| Revenues |
|
$426 million |
|
$383 million |
|
$414 million |
|
$1.55 billion
|
|
$1.30 billion
|
Earnings From
Operations |
|
$76 million |
|
$57 million |
|
$120 million |
|
$229 million |
|
$266 million |
Operating
Margin |
|
17.8% |
|
14.9% |
|
29.0% |
|
14.8% |
|
20.4% |
Key Developments for Ingenix
- On a
full year basis, Ingenix revenues increased $248
million or 19 percent to $1.6 billion, including
an increase of $12 million or 3 percent
year-over-year to $426 million in the fourth
quarter of 2008.
- Ingenix
contract revenue backlog grew approximately $140
million or 8 percent on a year-over-year basis to
approximately $1.85 billion at year end. Sales
growth of 28 percent across the payer, provider,
government and other market segments has been
offset by the impact of cancellations in the
pharmaceutical services business in 2008.
- Ingenix
full year 2008 earnings from operations of $229
million decreased $37 million or 14 percent
year-over-year, with fourth quarter decreasing
$44 million or 37 percent year-over-year. Lower
full year and fourth quarter 2008 operating
margins were attributable to costs related to
cancelled contract research projects, employee
severance and lower customer utilization of
consulting services.
- In
2008 Ingenix made important strides in the public
sector, where sales increased 106 percent, and in
growing its international health services
consulting business, winning contracts to operate
6 primary care trusts in England.
Prescription Solutions(R)
Business Description Prescription
Solutions
Prescription Solutions offers a
comprehensive array of pharmacy benefit management and
specialty pharmacy management services to employer
groups, union trusts, seniors through Medicare
prescription drug plans, and commercial health plans.
|
|
| Quarterly and
Annual Financial Performance |
| |
|
|
|
|
| |
|
Three Months
Ended |
|
Year Ended |
| |
|
December 31,
2008 |
|
September 30,
2008 |
|
December 31,
2007 |
|
December 31,
2008 |
|
December 31,
2007 |
| Revenues |
|
$3.12 billion |
|
$3.07 billion |
|
$3.32 billion |
|
$12.57
billion |
|
$13.25
billion |
Earnings From
Operations |
|
$80 million |
|
$91 million |
|
$78 million |
|
$363 million |
|
$269 million |
Operating
Margin |
|
2.6% |
|
3.0% |
|
2.4% |
|
2.9% |
|
2.0% |
Key Developments for Prescription
Solutions
- Prescription
Solutions full year 2008 revenues of $12.6
billion decreased $676 million or 5 percent
year-over-year and fourth quarter revenues of
$3.1 billion decreased $194 million or 6 percent
year-over-year. These decreases were due to the
continuing market shift to lower-priced generic
drugs and a reduction in the number of people
served through Medicare Part D prescription drug
plans from the re-assignment of dual-eligible
enrollees in certain regions by CMS in 2008.
- In
2008 Prescription Solutions grew the number of
consumers served through unaffiliated benefit
plans by 15 percent, or more than 400,000 people.
The people served through these channels now
represent 30 percent of Prescription Solutions
10.6 million consumers.
- Full
year 2008 earnings from operations of $363
million increased by $94 million or 35 percent
year-over-year and fourth quarter earnings from
operations grew $2 million or 3 percent
year-over-year to $80 million. Increased profits
were driven by steady gains in mail service drug
fulfillment and by a continuing favorable mix
shift to generic pharmaceuticals.
- These
trends also drove 90 basis points of full year
2008 margin improvement to 2.9 percent at
Prescription Solutions, with fourth quarter
operating margin increasing 20 basis points
year-over-year to 2.6 percent. Generic usage
exceeded 68 percent of prescriptions filled in
the fourth quarter of 2008, an increase of more
than 4 percentage points year-over-year.
About UnitedHealth Group
UnitedHealth Group is a diversified health
and well-being company dedicated to making health care
work better. Headquartered in Minneapolis, Minn.,
UnitedHealth Group offers a broad spectrum of products
and services through six operating businesses:
UnitedHealthcare, Ovations, AmeriChoice, OptumHealth,
Ingenix and Prescription Solutions. Through its family of
businesses, UnitedHealth Group serves more than 70
million individuals nationwide. Visit www.unitedhealthgroup.com
for more information.
Earnings Conference Call
As previously announced, UnitedHealth
Group will discuss the Companys results, strategy
and future outlook on a conference call with investors at
8:45 a.m. Eastern time today. UnitedHealth Group will
host a live webcast of this conference call from the
Investors page of the Companys Web site
(www.unitedhealthgroup.com). The webcast replay of the
call will be available on the same site through February
5, 2009 following the live call. The conference call
replay can also be accessed by dialing 1-800-642-1687,
conference ID #28401255. This earnings release and the
Form 8-K dated January 22, 2009, which may also be
accessed from the Investors page of the Companys
web site, include a reconciliation of non-GAAP financial
measures.
Forward-Looking Statements
This press release may contain statements,
estimates, projections, guidance or outlook that
constitute forward-looking statements as
defined under U.S. federal securities laws. Generally the
words believe, expect, intend,
estimate, anticipate, plan,
project, will, should
and similar expressions, identify forward-looking
statements, which generally are not historical in nature.
These statements may contain information about financial
prospects, economic conditions, trends and uncertainties
and involve risks and uncertainties. We caution that
actual results could differ materially from those that
management expects, depending on the outcome of certain
factors. Some factors that could cause results to differ
materially from the forward-looking statements include:
the potential consequences of various governmental
reviews and litigation matters related to our historical
stock option practices and the potential consequences of
each of these matters on our business, credit ratings and
debt; increases in health care costs that are higher than
we anticipated in establishing our premium rates,
including increased consumption or costs of medical
services; heightened competition as a result of new
entrants into our market, and consolidation of health
care companies and suppliers; events that may negatively
affect our contracts with AARP; uncertainties regarding
changes in Medicare, including coordination of
information systems and accuracy of certain assumptions;
funding risks with respect to revenues received from
Medicare and Medicaid programs; failure to achieve
business growth targets, including membership and
enrollment; increases in costs and other liabilities
associated with increased litigation, legislative
activity and government regulation and review of our
industry; our ability to execute contracts on competitive
terms with physicians, hospitals and other service
professionals; regulatory and other risks associated with
the pharmacy benefits management industry; failure to
maintain effective and efficient information systems,
which could result in the loss of existing customers,
difficulties in attracting new customers, difficulties in
determining medical costs estimates and appropriate
pricing, customer and physician and health care
professional disputes, regulatory violations, increases
in operating costs, or other adverse consequences;
possible impairment of the value of our intangible assets
if future results do not adequately support goodwill and
intangible assets recorded for businesses that we
acquire; potential noncompliance by our business
associates with patient privacy data; misappropriation of
our proprietary technology; failure to complete or
receive anticipated benefits of acquisitions; change in
debt to total capital ratio that is lower or higher than
we anticipated; and the potential impact of the adverse
conditions in the global economy and extreme disruption
of financial markets on our revenues, sources of
liquidity, investment portfolio, and our results of
operations.
This list of important factors is not
intended to be exhaustive. A further list and description
of some of these risks and uncertainties can be found in
our reports filed with the Securities and Exchange
Commission from time to time, including the cautionary
statements in our annual reports on Form 10-K, quarterly
reports on Form 10-Q and current reports on Form 8-K. Any
or all forward-looking statements we make may turn out to
be wrong. You should not place undue reliance on
forward-looking statements, which speak only as of the
date they are made. We do not undertake to update or
revise any forward-looking statements.
1
Further explanations of the non-GAAP measures referred to
in this release and reconciliations to the comparable
GAAP measures are included in the attached financial
schedules.
UNITEDHEALTH
GROUP
Earnings Release Schedules and Supplementary
Information
Quarter and Full Year Ended December 31, 2008 |
| |
- Consolidated Statements of
Operations
- Non-GAAP Operating Results
Excluding Special Items
- Condensed Consolidated
Balance Sheets
- Condensed Consolidated
Statements of Cash Flows and Non-GAAP
Adjusted Cash Flows from Operating
Activities and Ratio of Adjusted Cash
Flows from Operating Activities to
Adjusted Net Earnings
- Segment Financial Information
- Medical Care Ratios
- Customer Profile Summary
|
| Use of
Non-GAAP Financial Measures |
| |
| Operating
results excluding special items and adjusted cash
flows from operating activities as used in the
press release are not calculated in accordance
with GAAP and should not be considered a
substitute for or superior to financial measures
calculated in accordance with GAAP. Management
believes that the use of each of these non-GAAP
financial measures improves the comparability of
our results between periods. These financial
measures provide investors and our management
with useful information to measure and forecast
our results of operations, to compare on a
consistent basis our results of operations for
the current period to that of prior periods, and
to compare our results of operations on a more
consistent basis against that of other companies
in the health care industry. |
| |
| These non-GAAP
financial measures have limitations in that they
do not reflect all of the special items or
certain cash payments associated with the
operations of our business as determined in
accordance with GAAP. As a result, one should not
consider these measures in isolation. We
compensate for these limitations by analyzing
current and future results on a GAAP basis as
well as non-GAAP basis, disclosing these GAAP
financial measures, and providing a
reconciliation from GAAP to non-GAAP financial
measures. |
| |
| |
UNITEDHEALTH
GROUP
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited) |
| |
|
|
|
|
|
|
|
|
|
| |
|
|
Three Months
Ended December 31, |
|
Year Ended
December 31, |
| |
|
|
|
|
|
|
|
|
|
| |
|
|
2008 (a) |
|
2007 |
|
2008 (b) |
|
2007 (c) |
| |
REVENUES |
|
|
|
|
|
|
|
|
| |
Premiums |
|
$ |
18,581 |
|
|
$ |
16,964 |
|
|
$ |
73,608 |
|
|
$ |
68,781 |
|
| |
Services |
|
|
1,295 |
|
|
|
1,202 |
|
|
|
5,152 |
|
|
|
4,608 |
|
| |
Products |
|
|
469 |
|
|
|
260 |
|
|
|
1,655 |
|
|
|
898 |
|
| |
Investment
and Other Income |
|
|
109 |
|
|
|
279 |
|
|
|
771 |
|
|
|
1,144 |
|
| |
|
|
|
|
|
|
|
|
|
| |
Total
Revenues |
|
|
20,454 |
|
|
|
18,705 |
|
|
|
81,186 |
|
|
|
75,431 |
|
| |
|
|
|
|
|
|
|
|
|
| |
OPERATING
COSTS |
|
|
|
|
|
|
|
|
| |
Medical
Costs |
|
|
15,015 |
|
|
|
13,551 |
|
|
|
60,359 |
|
|
|
55,435 |
|
| |
Operating
Costs |
|
|
3,486 |
|
|
|
2,698 |
|
|
|
13,103 |
|
|
|
10,583 |
|
| |
Cost of
Products Sold |
|
|
415 |
|
|
|
211 |
|
|
|
1,480 |
|
|
|
768 |
|
| |
Depreciation
and Amortization |
|
|
259 |
|
|
|
207 |
|
|
|
981 |
|
|
|
796 |
|
| |
|
|
|
|
|
|
|
|
|
| |
Total
Operating Costs |
|
|
19,175 |
|
|
|
16,667 |
|
|
|
75,923 |
|
|
|
67,582 |
|
| |
|
|
|
|
|
|
|
|
|
| |
EARNINGS
FROM OPERATIONS |
|
|
1,279 |
|
|
|
2,038 |
|
|
|
5,263 |
|
|
|
7,849 |
|
| |
|
|
|
|
|
|
|
|
|
| |
Interest
Expense |
|
|
(155 |
) |
|
|
(153 |
) |
|
|
(639 |
) |
|
|
(544 |
) |
| |
|
|
|
|
|
|
|
|
|
| |
EARNINGS
BEFORE INCOME TAXES |
|
|
1,124 |
|
|
|
1,885 |
|
|
|
4,624 |
|
|
|
7,305 |
|
| |
|
|
|
|
|
|
|
|
|
| |
Provision
for Income Taxes |
|
|
(398 |
) |
|
|
(669 |
) |
|
|
(1,647 |
) |
|
|
(2,651 |
) |
| |
|
|
|
|
|
|
|
|
|
| |
NET EARNINGS
|
|
$ |
726 |
|
|
$ |
1,216 |
|
|
$ |
2,977 |
|
|
$ |
4,654 |
|
| |
|
|
|
|
|
|
|
|
|
| |
DILUTED NET
EARNINGS PER COMMON SHARE |
|
$ |
0.60 |
|
|
$ |
0.92 |
|
|
$ |
2.40 |
|
|
$ |
3.42 |
|
| |
|
|
|
|
|
|
|
|
|
| |
Diluted
Weighted-Average Common Shares Outstanding |
|
|
1,213 |
|
|
|
1,318 |
|
|
|
1,241 |
|
|
|
1,361 |
|
| |
|
|
|
|
|
|
|
|
|
| (a) |
Includes
pre-tax Operating Costs of $350 million for
settlement of class action litigation related to
reimbursement for out-of-network medical
services, partially offset by a net reduction in
pre-tax Operating Costs of $10 million for
insurance recoveries and legal fees related to
various matters. |
| |
|
|
|
|
|
|
|
|
|
| (b) |
Includes
items discussed in (a) above and pre-tax
Operating Costs from prior quarters of $882
million for settlement of two class action
lawsuits and related legal costs, $46 million for
employee severance related to operating cost
reduction initiatives and other items, partially
offset by a $185 million reduction in Operating
Costs for proceeds from the sale of certain
assets and membership in the individual Medicare
Advantage business in Nevada. |
| |
|
|
|
|
|
|
|
|
|
| (c) |
Includes
$87 million of Operating Costs for the settlement
of Internal Revenue Code Section 409A (IRS
Section 409A) surtax liabilities on behalf of
non-officer employees who exercised certain
options in 2006 and 2007, and $89 million of
non-cash Operating Costs for the modification
charge due to repricing unexercised options
subject to IRS Section 409A. |
| |
|
| |
UNITEDHEALTH
GROUP
Reconciliation of Non-GAAP Measures
Operating Results Excluding Special Items
(in millions, except per share data and
percentages)
(unaudited) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Quarter Ended
December 31, 2008 |
|
Quarter
Ended September 30, 2008 |
| |
|
|
Consolidated
GAAP
Reporting |
|
Non-GAAP
Reconciling
Items |
|
Operating
Results
Excluding Items (a) |
|
Consolidated
GAAP
Reporting |
|
Non-GAAP
Reconciling
Items |
|
Operating
Results
Excluding Items (b) |
| |
REVENUES |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Premiums |
|
$ |
18,581 |
|
|
$ |
- |
|
|
$ |
18,581 |
|
|
$ |
18,294 |
|
|
$ |
- |
|
|
$ |
18,294 |
|
| |
Services |
|
|
1,295 |
|
|
|
- |
|
|
|
1,295 |
|
|
|
1,287 |
|
|
|
- |
|
|
|
1,287 |
|
| |
Products |
|
|
469 |
|
|
|
- |
|
|
|
469 |
|
|
|
432 |
|
|
|
- |
|
|
|
432 |
|
| |
Investment
and Other Income |
|
|
109 |
|
|
|
- |
|
|
|
109 |
|
|
|
143 |
|
|
|
- |
|
|
|
143 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total
Revenues |
|
|
20,454 |
|
|
|
- |
|
|
|
20,454 |
|
|
|
20,156 |
|
|
|
- |
|
|
|
20,156 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
OPERATING
COSTS |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Medical
Costs |
|
|
15,015 |
|
|
|
- |
|
|
|
15,015 |
|
|
|
14,943 |
|
|
|
- |
|
|
|
14,943 |
|
| |
Operating
Costs |
|
|
3,486 |
|
|
|
(340 |
) |
|
|
3,146 |
|
|
|
2,974 |
|
|
|
40 |
|
|
|
3,014 |
|
| |
Cost of
Products Sold |
|
|
415 |
|
|
|
- |
|
|
|
415 |
|
|
|
387 |
|
|
|
- |
|
|
|
387 |
|
| |
Depreciation
and Amortization |
|
|
259 |
|
|
|
- |
|
|
|
259 |
|
|
|
254 |
|
|
|
- |
|
|
|
254 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total
Operating Costs |
|
|
19,175 |
|
|
|
(340 |
) |
|
|
18,835 |
|
|
|
18,558 |
|
|
|
40 |
|
|
|
18,598 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
EARNINGS
FROM OPERATIONS |
|
|
1,279 |
|
|
|
340 |
|
|
|
1,619 |
|
|
|
1,598 |
|
|
|
(40 |
) |
|
|
1,558 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Interest
Expense |
|
|
(155 |
) |
|
|
- |
|
|
|
(155 |
) |
|
|
(166 |
) |
|
|
- |
|
|
|
(166 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
EARNINGS
BEFORE INCOME TAXES |
|
|
1,124 |
|
|
|
340 |
|
|
|
1,464 |
|
|
|
1,432 |
|
|
|
(40 |
) |
|
|
1,392 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Provision
for Income Taxes |
|
|
(398 |
) |
|
|
(125 |
) |
|
|
(523 |
) |
|
|
(512 |
) |
|
|
15 |
|
|
|
(497 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
NET EARNINGS
|
|
$ |
726 |
|
|
$ |
215 |
|
|
$ |
941 |
|
|
$ |
920 |
|
|
$ |
(25 |
) |
|
$ |
895 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
DILUTED NET
EARNINGS PER COMMON SHARE |
|
$ |
0.60 |
|
|
$ |
0.18 |
|
|
$ |
0.78 |
|
|
$ |
0.75 |
|
|
$ |
(0.02 |
) |
|
$ |
0.73 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Diluted
Weighted-Average Common Shares Outstanding |
|
|
1,213 |
|
|
|
|
|
1,213 |
|
|
|
1,227 |
|
|
|
|
|
1,227 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Medical Care
Ratio |
|
|
80.8 |
% |
|
|
|
|
80.8 |
% |
|
|
81.7 |
% |
|
|
|
|
81.7 |
% |
| |
Operating
Cost Ratio |
|
|
17.0 |
% |
|
|
|
|
15.4 |
% |
|
|
14.8 |
% |
|
|
|
|
15.0 |
% |
| |
Operating
Margin |
|
|
6.3 |
% |
|
|
|
|
7.9 |
% |
|
|
7.9 |
% |
|
|
|
|
7.7 |
% |
| |
Income Tax
Rate |
|
|
35.4 |
% |
|
|
|
|
35.7 |
% |
|
|
35.8 |
% |
|
|
|
|
35.7 |
% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (a) |
Excludes
pre-tax Operating Costs of $350 million for
settlement of class action litigation related to
reimbursement for out-of-network medical
services, partially offset by a net reduction in
pre-tax Operating Costs of $10 million for
insurance recoveries and legal fees related to
various matters. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (b) |
Excludes a
reduction in pre-tax Operating Costs of $40
million from a change in estimated net costs to
settle two class action lawsuits related to the
Company's historical stock option practices. |
| |
|
| |
UNITEDHEALTH
GROUP
Reconciliation of Non-GAAP Measures
Operating Results Excluding Special Items
(in millions, except per share data and
percentages)
(unaudited) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Year Ended
December 31, 2008 |
|
Year Ended
December 31, 2007 |
| |
|
|
Consolidated
GAAP
Reporting |
|
Non-GAAP
Reconciling
Items |
|
Operating
Results
Excluding Items (a) |
|
Consolidated
GAAP
Reporting |
|
Non-GAAP
Reconciling
Items |
|
Operating
Results
Excluding Items (b) |
| |
REVENUES |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Premiums |
|
$ |
73,608 |
|
|
$ |
- |
|
|
$ |
73,608 |
|
|
$ |
68,781 |
|
|
$ |
- |
|
|
$ |
68,781 |
|
| |
Services |
|
|
5,152 |
|
|
|
- |
|
|
|
5,152 |
|
|
|
4,608 |
|
|
|
- |
|
|
|
4,608 |
|
| |
Products |
|
|
1,655 |
|
|
|
- |
|
|
|
1,655 |
|
|
|
898 |
|
|
|
- |
|
|
|
898 |
|
| |
Investment
and Other Income |
|
|
771 |
|
|
|
- |
|
|
|
771 |
|
|
|
1,144 |
|
|
|
- |
|
|
|
1,144 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total
Revenues |
|
|
81,186 |
|
|
|
- |
|
|
|
81,186 |
|
|
|
75,431 |
|
|
|
- |
|
|
|
75,431 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
OPERATING
COSTS |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Medical
Costs |
|
|
60,359 |
|
|
|
- |
|
|
|
60,359 |
|
|
|
55,435 |
|
|
|
- |
|
|
|
55,435 |
|
| |
Operating
Costs |
|
|
13,103 |
|
|
|
(1,083 |
) |
|
|
12,020 |
|
|
|
10,583 |
|
|
|
(176 |
) |
|
|
10,407 |
|
| |
Cost of
Products Sold |
|
|
1,480 |
|
|
|
- |
|
|
|
1,480 |
|
|
|
768 |
|
|
|
- |
|
|
|
768 |
|
| |
Depreciation
and Amortization |
|
|
981 |
|
|
|
- |
|
|
|
981 |
|
|
|
796 |
|
|
|
- |
|
|
|
796 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total
Operating Costs |
|
|
75,923 |
|
|
|
(1,083 |
) |
|
|
74,840 |
|
|
|
67,582 |
|
|
|
(176 |
) |
|
|
67,406 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
EARNINGS
FROM OPERATIONS |
|
|
5,263 |
|
|
|
1,083 |
|
|
|
6,346 |
|
|
|
7,849 |
|
|
|
176 |
|
|
|
8,025 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Interest
Expense |
|
|
(639 |
) |
|
|
- |
|
|
|
(639 |
) |
|
|
(544 |
) |
|
|
- |
|
|
|
(544 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
EARNINGS
BEFORE INCOME TAXES |
|
|
4,624 |
|
|
|
1,083 |
|
|
|
5,707 |
|
|
|
7,305 |
|
|
|
176 |
|
|
|
7,481 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Provision
for Income Taxes |
|
|
(1,647 |
) |
|
|
(400 |
) |
|
|
(2,047 |
) |
|
|
(2,651 |
) |
|
|
(64 |
) |
|
|
(2,715 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
NET EARNINGS
|
|
$ |
2,977 |
|
|
$ |
683 |
|
|
$ |
3,660 |
|
|
$ |
4,654 |
|
|
$ |
112 |
|
|
$ |
4,766 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
DILUTED NET
EARNINGS PER COMMON SHARE |
|
$ |
2.40 |
|
|
$ |
0.55 |
|
|
$ |
2.95 |
|
|
$ |
3.42 |
|
|
$ |
0.08 |
|
|
$ |
3.50 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Diluted
Weighted-Average Common Shares Outstanding |
|
|
1,241 |
|
|
|
|
|
1,241 |
|
|
|
1,361 |
|
|
|
|
|
1,361 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Medical Care
Ratio |
|
|
82.0 |
% |
|
|
|
|
82.0 |
% |
|
|
80.6 |
% |
|
|
|
|
80.6 |
% |
| |
Operating
Cost Ratio |
|
|
16.1 |
% |
|
|
|
|
14.8 |
% |
|
|
14.0 |
% |
|
|
|
|
13.8 |
% |
| |
Operating
Margin |
|
|
6.5 |
% |
|
|
|
|
7.8 |
% |
|
|
10.4 |
% |
|
|
|
|
10.6 |
% |
| |
Income Tax
Rate |
|
|
35.6 |
% |
|
|
|
|
35.9 |
% |
|
|
36.3 |
% |
|
|
|
|
36.3 |
% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (a) |
Excludes
pre-tax Operating Costs of $350 million for
settlement of class action litigation related to
reimbursement for out-of-network medical
services, partially offset by a net reduction in
pre-tax Operating Costs of $10 million for
insurance recoveries and legal fees related to
various matters, and pre-tax Operating Costs from
prior quarters of $882 million for settlement of
two class action lawsuits and related legal
costs, $46 million for employee severance related
to operating cost reduction initiatives and other
items, partially offset by a $185 million
reduction in Operating Costs for proceeds from
the sale of certain assets and membership in the
individual Medicare Advantage business in Nevada.
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (b) |
Excludes
$87 million of Operating Costs for the settlement
of Internal Revenue Code Section 409A (IRS
Section 409A) surtax liabilities on behalf of
non-officer employees who exercised certain
options in 2006 and 2007, and $89 million of
non-cash Operating Costs for the modification
charge due to repricing unexercised options
subject to IRS Section 409A. |
| |
|
UNITEDHEALTH
GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited) |
| |
|
|
|
|
| |
|
December 31,
2008 |
|
December 31,
2007 |
| |
|
|
|
|
| ASSETS |
|
|
|
|
| Cash and
Short-Term Investments |
|
$ |
8,209 |
|
$ |
9,619 |
| Accounts
Receivable, net |
|
|
1,929 |
|
|
1,574 |
| Other Current
Assets |
|
|
4,852 |
|
|
4,351 |
| |
|
|
|
|
| Total Current
Assets |
|
|
14,990 |
|
|
15,544 |
| |
|
|
|
|
| Long-Term
Investments |
|
|
13,366 |
|
|
12,667 |
| Other
Long-Term Assets |
|
|
27,459 |
|
|
22,688 |
| |
|
|
|
|
| Total Assets |
|
$ |
55,815 |
|
$ |
50,899 |
| |
|
|
|
|
| LIABILITIES
AND SHAREHOLDERS' EQUITY |
|
|
|
|
| Medical Costs
Payable |
|
$ |
8,664 |
|
$ |
8,331 |
| Commercial
Paper and Current Maturities of Long-Term Debt |
|
|
1,456 |
|
|
1,946 |
| Other Current
Liabilities |
|
|
10,070 |
|
|
8,215 |
| |
|
|
|
|
| Total Current
Liabilities |
|
|
20,190 |
|
|
18,492 |
| |
|
|
|
|
| Long-Term
Debt, less current maturities |
|
|
11,338 |
|
|
9,063 |
| Future Policy
Benefits for Life and Annuity Contracts |
|
|
1,857 |
|
|
1,849 |
| Deferred
Income Taxes and Other Liabilities |
|
|
1,650 |
|
|
1,432 |
| Shareholders'
Equity |
|
|
20,780 |
|
|
20,063 |
| |
|
|
|
|
| Total
Liabilities and Shareholders' Equity |
|
$ |
55,815 |
|
$ |
50,899 |
| |
|
|
|
|
|
|
UNITEDHEALTH
GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited) |
| |
|
|
|
|
| |
|
Year Ended
December 31, |
| |
|
2008 |
|
2007 |
| Operating
Activities |
|
|
|
|
| Net Earnings |
|
$ |
2,977 |
|
|
$ |
4,654 |
|
| Noncash Items:
|
|
|
|
|
| Depreciation
and amortization |
|
|
981 |
|
|
|
796 |
|
| Deferred
income taxes and other |
|
|
(288 |
) |
|
|
(127 |
) |
| Share-based
compensation |
|
|
305 |
|
|
|
505 |
|
| Net changes
in operating assets and liabilities |
|
|
263 |
|
|
|
49 |
|
| Cash Flows
From Operating Activities |
|
|
4,238 |
|
|
|
5,877 |
|
| |
|
|
|
|
| Investing
Activities |
|
|
|
|
| Cash paid for
acquisitions, net of cash assumed |
|
|
(3,813 |
) |
|
|
(262 |
) |
| Purchases of
property, equipment and capitalized software |
|
|
(791 |
) |
|
|
(871 |
) |
| Proceeds from
disposal of property, equipment and capitalized
software |
|
|
185 |
|
|
|
- |
|
| Net purchases
of investments |
|
|
(653 |
) |
|
|
(3,014 |
) |
| Cash Flows
Used For Investing Activities |
|
|
(5,072 |
) |
|
|
(4,147 |
) |
| |
|
|
|
|
| Financing
Activities |
|
|
|
|
| Common stock
repurchases |
|
|
(2,684 |
) |
|
|
(6,599 |
) |
| Net change in
commercial paper and debt |
|
|
1,135 |
|
|
|
3,569 |
|
| Share-based
compensation excess tax benefit |
|
|
62 |
|
|
|
303 |
|
| Customer
funds administered |
|
|
(461 |
) |
|
|
(1,110 |
) |
| Proceeds from
common stock issuances |
|
|
299 |
|
|
|
712 |
|
| Other, net |
|
|
1,044 |
|
|
|
(60 |
) |
| Cash Flows
Used For Financing Activities |
|
|
(605 |
) |
|
|
(3,185 |
) |
| |
|
|
|
|
| Decrease in
cash and cash equivalents |
|
|
(1,439 |
) |
|
|
(1,455 |
) |
| Cash and cash
equivalents, beginning of period |
|
|
8,865 |
|
|
|
10,320 |
|
| Cash and cash
equivalents, end of period |
|
$ |
7,426 |
|
|
$ |
8,865 |
|
| |
|
|
|
|
| |
|
|
|
|
| Non-GAAP
Adjusted Cash Flows from Operating Activities and
Ratio of Adjusted Cash Flows from
Operating Activities to Adjusted Net Earnings
(in
billions)
|
| |
|
Year Ended December
31, 2008
|
|
|
| GAAP Cash
Flows From Operating Activities |
|
$ |
4.2 |
|
|
|
| Legal
Settlement Payments, net of tax benefit |
|
|
0.6 |
|
(a) |
|
| Adjusted Cash
Flows From Operating Activities (a) |
|
$ |
4.8 |
|
|
|
| |
|
|
|
|
| Adjusted Net
Earnings |
|
$ |
3.7 |
|
|
|
| |
|
|
|
|
| Ratio of Cash
Flows From Operating Activities to Net Earnings |
|
|
1.4 |
|
|
|
| |
|
|
|
|
| Ratio of
Adjusted Cash Flows From Operating Activities to
Adjusted Net Earnings |
|
|
1.3 |
|
|
|
| |
|
|
|
|
| (a) Adjusted
Cash Flows From Operating Activities for the year
ended December 31, 2008 excludes net cash
payments to settle two class action lawsuits
related to the Company's historical stock option
practices. |
| |
UNITEDHEALTH
GROUP
SEGMENT FINANCIAL INFORMATION
(in millions)
(unaudited) |
| |
|
|
|
|
|
|
|
|
|
| REVENUES |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
Three Months
Ended December 31, |
|
Twelve
Months Ended December 31, |
| |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
| |
|
|
|
|
|
|
|
|
|
| |
Health Care
Services (a) |
|
$ |
19,080 |
|
|
$ |
17,572 |
|
|
$ |
75,857 |
|
|
$ |
71,199 |
|
| |
OptumHealth |
|
|
1,306 |
|
|
|
1,255 |
|
|
|
5,225 |
|
|
|
4,921 |
|
| |
Ingenix |
|
|
426 |
|
|
|
414 |
|
|
|
1,552 |
|
|
|
1,304 |
|
| |
Prescription
Solutions |
|
|
3,123 |
|
|
|
3,317 |
|
|
|
12,573 |
|
|
|
13,249 |
|
| |
Eliminations
|
|
|
(3,481 |
) |
|
|
(3,853 |
) |
|
|
(14,021 |
) |
|
|
(15,242 |
) |
| |
Total
Consolidated |
|
$ |
20,454 |
|
|
$ |
18,705 |
|
|
$ |
81,186 |
|
|
$ |
75,431 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| EARNINGS
FROM OPERATIONS |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
Three Months
Ended December 31, |
|
Twelve
Months Ended December 31, |
| |
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
| |
|
|
|
|
|
|
|
|
|
| |
Health Care
Services |
|
$ |
1,268 |
|
|
$ |
1,601 |
|
|
$ |
5,068 |
|
|
$ |
6,595 |
|
| |
OptumHealth |
|
|
177 |
|
|
|
239 |
|
|
|
718 |
|
|
|
895 |
|
| |
Ingenix |
|
|
76 |
|
|
|
120 |
|
|
|
229 |
|
|
|
266 |
|
| |
Prescription
Solutions |
|
|
80 |
|
|
|
78 |
|
|
|
363 |
|
|
|
269 |
|
| |
Corporate |
|
|
(322 |
) |
|
|
- |
|
|
|
(1,115 |
) |
|
|
(176 |
) |
| |
Total
Consolidated |
|
$ |
1,279 |
|
|
$ |
2,038 |
|
|
$ |
5,263 |
|
|
$ |
7,849 |
|
| |
|
|
|
|
|
|
|
|
|
| (a) |
Revenues
for the three and twelve months ended December
31, 2008 were $10,527 and $41,838 for
UnitedHealthcare; $6,848 and $28,052 for
Ovations; and $1,705 and $5,967 for AmeriChoice,
respectively. Revenues for the three and twelve
months ended December 31, 2007 were $10,104 and
$40,288 for UnitedHealthcare; $6,278 and $26,460
for Ovations; and $1,190 and $4,451 for
AmeriChoice, respectively. |
| |
|
UNITEDHEALTH
GROUP
Medical Care Ratios
(unaudited) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Three Months
Ended |
|
Year Ended |
|
Three Months
Ended |
|
Year Ended |
| |
March 31,
2008 |
|
June 30,
2008 |
|
September 30,
2008 |
|
December 31,
2008 |
|
December 31,
2008 |
|
March 31,
2007 |
|
June 30,
2007 |
|
September
30,
2007 |
|
December 31,
2007 |
|
December 31,
2007 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth
Group Consolidated |
82.4% |
|
83.2% |
|
81.7% |
|
80.8% |
|
82.0% |
|
82.7% |
|
80.3% |
|
79.5% |
|
79.9% |
|
80.6% |
| UnitedHealthcare
(a) |
82.5% |
|
83.8% |
|
83.8% |
|
83.9% |
|
83.5% |
|
81.8% |
|
82.4% |
|
82.0% |
|
84.1% |
|
82.6% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (a) Includes
UnitedHealthcare National Accounts |
| |
UNITEDHEALTH
GROUP
CUSTOMER PROFILE SUMMARY
ALL BUSINESS UNITS
(in thousands)
(unaudited) |
| |
|
|
|
|
|
|
| People Served
|
|
December 31,
2008 |
|
September 30,
2008 |
|
December
31,
2007 |
| |
|
|
|
|
|
|
| Commercial
Risk-based |
|
10,360 |
|
10,495 |
|
10,805 |
| Commercial
Fee-based |
|
15,985 |
|
15,975 |
|
14,720 |
| |
|
|
|
|
|
|
| Total
Commercial |
|
26,345 |
|
26,470 |
|
25,525 |
| |
|
|
|
|
|
|
| Medicare
Advantage |
|
1,495 |
|
1,480 |
|
1,370 |
| Medicaid |
|
2,515 |
|
2,340 |
|
1,710 |
| Standardized
Medicare Supplement |
|
2,540 |
|
2,510 |
|
2,400 |
| |
|
|
|
|
|
|
| Total Public
and Senior (a) |
|
6,550 |
|
6,330 |
|
5,480 |
| |
|
|
|
|
|
|
| Total Health
Care Services Medical Benefits |
|
32,895 |
|
32,800 |
|
31,005 |
| |
|
|
|
|
|
|
| Total People
Served |
|
72,800 |
|
72,820 |
|
70,950 |
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| Supplemental
Data - included in Total People Served |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| OptumHealth |
|
59,700 |
|
59,600 |
|
58,700 |
| |
|
|
|
|
|
|
| Total Part D
Prescription Drug Plans |
|
5,450 |
|
5,465 |
|
5,950 |
| |
|
|
|
|
|
|
| Consumer-Driven
Health Plans |
|
2,735 |
|
2,740 |
|
2,315 |
| |
|
|
|
|
|
|
| (a)
Excludes pre-standardized Medicare Supplement and
other AARP products. These people are included in
Total People Served. |
|